Molecular Therapy
Molecular Therapy is a subscription (hybrid open access) journal published by Elsevier BV in the United States. OpenAlex counts 23,006 works from it, cited 516,457 times; its h-index is 272. Its two-year mean citedness, which is computed the way the impact factor is, is 8.04: a paper it published in the two years before was cited about 8.04 times last year. It published 608 papers in 2025, up 39% from 436 in 2024. Publishing a paper open access in it costs about US$4,500.
- Publisher
- Elsevier BV
- Citations per paper
- 8.04 two-year mean, OpenAlex
- h-index
- 272 i10-index 5,683
- Access
- Subscription · hybrid open access
- APC
- US$4,500 to publish open access
- ISSN
- 1525-0016, 1525-0024
- Country
- United States
- Works published
- 23,006 cited 516,457 times
- Papers in 2025
- 608
- Website
- Journal home ↗
Molecular Therapy year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 486 | 37,465 |
| 2025 | 608 | 39,760 |
| 2024 | 436 | 38,869 |
| 2023 | 289 | 36,132 |
| 2022 | 291 | 34,483 |
| 2021 | 318 | 34,689 |
| 2020 | 332 | 29,895 |
| 2019 | 252 | 24,783 |
What Molecular Therapy publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Virus-based gene therapy researchGenetics · 15,064 papers
- RNA Interference and Gene DeliveryMolecular Biology · 10,649 papers
- Immunotherapy and Immune ResponsesImmunology · 3,525 papers
- CRISPR and Genetic EngineeringMolecular Biology · 2,495 papers
- Nanoparticle-Based Drug DeliveryBiomaterials · 1,557 papers
Questions about Molecular Therapy
What is the impact factor of Molecular Therapy?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 8.04 for Molecular Therapy: on average, each paper it published in the two years before was cited about 8.04 times in a year.
What is the h-index of Molecular Therapy?
272, by OpenAlex's count: 272 of its papers have each been cited at least 272 times. Its i10-index is 5,683.
Is Molecular Therapy open access?
Not fully. Molecular Therapy is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the publication fee (APC) of Molecular Therapy?
About US$4,500, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Molecular Therapy?
Its linking ISSN is 1525-0016; all its ISSNs: 1525-0016, 1525-0024.
Who publishes Molecular Therapy?
Elsevier BV, based in the United States.
How many papers does Molecular Therapy publish a year?
608 in 2025, by OpenAlex's count of what it published that year.
What does Molecular Therapy publish?
Its most frequent research topics are Virus-based gene therapy research, RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, in the field of Biochemistry, Genetics and Molecular Biology.
Is Molecular Therapy a predatory journal?
Nothing in the scholarly indexes suggests so. Molecular Therapy is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 23,006 works cited 516,457 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Molecular Therapy indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1525-0016): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Molecular Therapy
Other Biochemistry, Genetics and Molecular Biology journals with a similar impact.
Every Biochemistry, Genetics and Molecular Biology journal, ranked · The journal directory
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).